Sangamo Therapeutics, Inc. Stock
Stocks
SGMOQ
US8006771062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
23:56:10 18/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1100 USD | 0.00% |
|
+3.77% | -73.81% |
| Market Cap | 45.57M 41.56M 38.43M 34.68M 65.31M 4.26B 67.89M 464M 183M 2.3B 171M 167M 7.26B | P/E 2024 |
-2.1x | P/E 2025 | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 51.42M 46.89M 43.36M 39.13M 73.69M 4.8B 76.6M 524M 207M 2.59B 193M 189M 8.19B | EV / Sales 2024 |
3.49x | EV / Sales 2025 | 3.72x |
| Free-Float |
99.07% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| SGMOQ | Delayed | |
| 0R1D | Delayed |
Last Transcript: Sangamo Therapeutics, Inc.
| 1 week | +3.77% | ||
| Current month | -5.17% | ||
| 1 month | -0.18% | ||
| 3 months | -31.03% | ||
| 6 months | -13.79% | ||
| Current year | -73.81% |
| 1 week | 0.1 | 0.12 | |
| 1 month | 0.07 | 0.13 | |
| Current year | 0.01 | 0.6 | |
| 1 year | 0.01 | 0.6 | |
| 3 years | 0.01 | 3.18 | |
| 5 years | 0.01 | 9.3 | |
| 10 years | 0.01 | 27.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 63 | 01/06/2016 |
Nikunj Jain
DFI | Director of Finance/CFO | 47 | 03/02/2026 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | 29/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Parker
CHM | Chairman | 70 | 01/06/2017 |
Alexander Macrae
BRD | Director/Board Member | 63 | 01/06/2016 |
Robert Carey
BRD | Director/Board Member | 68 | 01/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/25/26 A | Tax | General Counsel | -4,036 | 0.0010% | ||
| 5/25/26 A | Tax | Executive/Senior Manager | -4,036 | 0.0010% | ||
| 5/25/26 A | Tax | Chief Executive Officer | -12,613 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +3.77% | -73.89% | -71.41% | 45.57M | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 65.45B | ||
| -0.40% | -3.45% | +7.35% | +89.93% | 58.93B | ||
| +0.60% | +0.75% | +26.70% | +87.85% | 55.21B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 46.1B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.49B | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 35.56B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 34.57B | ||
| +0.54% | 0.00% | +78.37% | +59.01% | 32.46B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.28B | ||
| Average | -0.88% | -2.69% | +22.86% | +144.93% | 40B | |
| Weighted average by Cap. | -0.90% | -3.29% | +33.69% | +143.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 57.8M 52.71M 48.74M 43.98M 82.84M 5.4B 86.1M 589M 233M 2.92B 217M 212M 9.21B | 39.55M 36.07M 33.35M 30.1M 56.69M 3.7B 58.92M 403M 159M 1.99B 148M 145M 6.3B |
| Net income | -97.94M -89.32M -82.59M -74.53M -140M -9.15B -146M -997M -394M -4.94B -367M -360M -15.6B | -123M -112M -104M -93.55M -176M -11.49B -183M -1.25B -495M -6.2B -461M -452M -19.58B |
| Net Debt | -11.35M -10.35M -9.57M -8.64M -16.27M -1.06B -16.91M -116M -45.7M -573M -42.59M -41.7M -1.81B | 5.85M 5.33M 4.93M 4.45M 8.38M 546M 8.71M 59.55M 23.54M 295M 21.94M 21.48M 931M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | $0.1100 | 0.00% | 211,891 |
| 17/11/26 | $0.1100 | +1.01% | 333,804 |
| 16/11/26 | $0.1089 | -6.92% | 871,736 |
| 13/11/26 | $0.1170 | +6.36% | 219,301 |
| 12/11/26 | $0.1100 | +3.77% | 731,530 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SGMOQ Stock
Select your edition
All financial news and data tailored to specific country editions
















